Back
Caribou Biosciences Vs. Celldex Therapeutics Industry Stock Comparison
Sell
49
CRBU
Caribou Biosciences
Last Price:
2.07
Seasonality Move:
-21.17%
Buy
57
CLDX
Celldex Therapeutics
Last Price:
41.23
Seasonality Move:
-1.09%
Sell
49
Caribou Biosciences (CRBU)
is a Sell
Is Caribou Biosciences a Buy, Sell or Hold?
- The current Caribou Biosciences [CRBU] share price is $2.06. The Score for CRBU is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRBU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $41.24. The Score for CLDX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- CLDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRBU Stock Price Chart
What is Caribou Biosciences's stock price today?
-
The Caribou Biosciences share price today is $2.06
The current trend is relatively stagnant and CRBU is experiencing slight buying pressure.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $41.24
The current trend is moderately bullish and CLDX is experiencing slight buying pressure.
CRBU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.88 | Buy |
| Chaikin Money Flow: | 320594 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.92 - 2.18) | Buy |
| Bollinger Bands (100): | (1.69 - 2.97) | Sell |
CLDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.21 | Buy |
| Relative Strength Index (14 RSI): | 53.83 | Buy |
| Chaikin Money Flow: | 95335 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.1 - 43.14) | Buy |
| Bollinger Bands (100): | (34.55 - 41.03) | Buy |
CRBU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.07 | Sell |
| 20-day SMA: | 2.03 | Buy |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 4.02 | Sell |
| 8-day EMA: | 2.05 | Buy |
| 20-day EMA: | 2.04 | Buy |
| 50-day EMA: | 2.13 | Sell |
| 200-day EMA: | 3.47 | Sell |
CLDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.99 | Sell |
| 20-day SMA: | 41.32 | Sell |
| 50-day SMA: | 38.51 | Buy |
| 200-day SMA: | 38.76 | Buy |
| 8-day EMA: | 41.74 | Sell |
| 20-day EMA: | 40.88 | Buy |
| 50-day EMA: | 39.17 | Buy |
| 200-day EMA: | 37.58 | Buy |
Caribou Biosciences Earnings Growth & CRBU Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.53 per share, and a decrease next year of $0.12 per share.
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Caribou Biosciences Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Celldex Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||